Filing Details

Accession Number:
0001179110-22-000392
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-11 16:14:30
Reporting Period:
2022-01-07
Accepted Time:
2022-01-11 16:14:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574579 Dawn Svoronos C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-07 510 $38.53 26,555 No 4 S Direct
Common Stock Acquisiton 2022-01-07 3,200 $0.00 29,755 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Acquisiton 2022-01-07 12,000 $0.00 12,000 $38.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,000 2032-01-06 No 4 A Direct
Footnotes
  1. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 963 RSUs from a January 6, 2021 grant of 1,650 RSUs.
  2. Restricted stock units granted on January 7, 2022 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 8, 2022 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 7, 2023.
  3. This option was granted on January 7, 2022 and vests over one year in twelve equal monthly installments, commencing on February 7, 2022.